|
A more recent version of this article appeared on April 14, 2006
Papers In Press, published online ahead of print February 9, 2006
J. Biol. Chem, 10.1074/jbc.M512009200
Submitted on November 8, 2005
Revised on February 7, 2006
Accepted on February 9, 2006
Individual timp deficiencies differentially impact pro-MMP-2 activaiton
Jane L. English, Zamaneh Kassiri, Ilpo Koskivirta, Susan J. Atkinson, Marco Di Grappa, Paul D. Soloway, Hideaki Nagase, Eero Vuorio, Gillian Murphy, and Rama Khokha
Onatrio Cancer Institute, Room# 10-330, Toronto, Ontario M5G 2M9
Corresponding Author: rkhokha{at}uhnres.utoronto.ca
Membrane-type matrix metalloproteinases (MT-MMPs) have emerged as key enzymes in tumour cell biology. The importance of MT1-MMP in particular, is highlighted by its ability to activate pro-MMP-2 at the cell surface through the formation of a trimolecular complex comprised of MT1-MMP/tissue inhibitor of metalloproteinase-2 (TIMP-2)/pro-MMP-2. TIMPs 1-4 are physiological MMP inhibitors with distinct roles in the regulation of pro-MMP-2 processing. Here, we show that individual timp-deficiencies differentially affect MMP-2 processing using primary mouse embryonic fibroblasts (MEFs). Timp-3 deficiency accelerated pro-MMP-2 activation in response to both cytochalasin D and concanavalin A. Exogenous TIMP-2 and N-TIMP-3 inhibited this activation, whereas TIMP-3 containing matrix from wild type (WT) MEFs did not rescue the enhanced MMP-2 activation in Timp-3-/- cells. Increased processing of MMP-2 did not arise from increased expression of MT1-MMP, MT2-MMP or MT3-MMP, or altered expression of TIMP-2 and MMP-2. To test whether increased MMP-2 processing in Timp-3-/- MEFs is dependent on TIMP-2, double deficient Timp-2-/-/-3-/- cells were used. In these double deficient cells, the cleavage of pro-MMP-2 to its intermediate form was substantially increased, but the subsequent cleavage of intermediate-MMP-2 to fully active, while absent in Timp-2-/- MEFs, was detectable with combined Timp-2-/-/-3-/- deficiency. TIMP-4 associates with MMP-2 and MT1-MMP in a manner similar to TIMP-3, but its deletion had no effect on pro-MMP-2 processing. Thus, TIMP-3 provides an inherent regulation over the kinetics of pro-MMP-2 processing, serving at a level distinct from that of TIMP-2 and TIMP-4.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Gabriely, T. Wurdinger, S. Kesari, C. C. Esau, J. Burchard, P. S. Linsley, and A. M. Krichevsky
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Mol. Cell. Biol.,
September 1, 2008;
28(17):
5369 - 5380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Johnson, G. B. Sala-Newby, Y. Ismail, C. M. Aguilera, and A. C. Newby
Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2008;
28(9):
1647 - 1653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chen, J. K. McGuire, R. C. Hackman, K.-H. Kim, R. A. Black, K. Poindexter, W. Yan, P. Liu, A. J. Chen, W. C. Parks, et al.
Tissue Inhibitor of Metalloproteinase-1 Moderates Airway Re-Epithelialization by Regulating Matrilysin Activity
Am. J. Pathol.,
May 1, 2008;
172(5):
1256 - 1270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev,
October 1, 2007;
87(4):
1285 - 1342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Sun, C. R. Weber, A. Sohail, M. M. Bernardo, M. Toth, H. Zhao, J. R. Turner, and R. Fridman
MMP25 (MT6-MMP) Is Highly Expressed in Human Colon Cancer, Promotes Tumor Growth, and Exhibits Unique Biochemical Properties
J. Biol. Chem.,
July 27, 2007;
282(30):
21998 - 22010.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|